This covert infection is theorized to develop as a result of “immune pressure” from these treatments, which result in viral mutations eluding the host, and result in failure to produce detectable antibodies. These mutations accumulate in vaccinated children and can be transmitted from mother to child.
What this means is that, current practice, as applied to the group of people most appropriate for the intervention (those infants of infected mothers we were hoping to protect), is not effective at preventing infection and may contribute to mutations in the virus that allow for covert infection.
So, if it works even 1% more than a coin toss in preventing infection, than why not just do it?
Because it is a toxic exposure that has unknown and unpredictable effects. It has never been appropriately studied in humans (true placebo control), and what we are observing from population-based reports is that 443,093 adverse events (headache, irritability, extreme fatigue, brain inflammation, convulsions, rheumatoid arthritis, optic neuritis, multiple sclerosis, lupus, Guillain-Barre Syndrome (GBS) and neuropathy ) have been registered including >1500 deaths, often labeled as Sudden Infant Death Syndrome. NVIC discusses: